A mechanism by which SERT inhibitors could worsen Parkinsonism may involve 5-HT-mediated activation of 5-HT2C receptors within the SN, which leads to a decrease in nigrostriatal dopaminergic transmission [126]. This evidence concerns the gene HTR5A and Parkinson disease.